Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jover

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 1, 1994
[Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog]F Bertolino, J P Valentin, M Maffre, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonistF Bertolino, J P Valentin, M Maffre, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Influence of the renal kallikrein-kinin system on renal function in the ratA Mimran, D Casellas, B Jover, et al.
American Journal of Hypertension|November 5, 1997
Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the ratJ P Valentin, B Jover, M Maffre, et al.
Cardiovascular Toxicology|July 28, 2011
Carbon monoxide pollution impairs myocardial perfusion reserve: implication of coronary endothelial dysfunctionG Meyer, J Boissiere, S Tanguy, et al.
Clinical and Experimental Pharmacology & Physiology|September 1, 1987
Atrial natriuretic peptide release in the rabbit is independent of cardiac nerve activityB P McGrath, D Blake, B Jover, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 1, 1994
[Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog]F Bertolino, J P Valentin, M Maffre, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonistF Bertolino, J P Valentin, M Maffre, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Influence of the renal kallikrein-kinin system on renal function in the ratA Mimran, D Casellas, B Jover, et al.
American Journal of Hypertension|November 5, 1997
Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the ratJ P Valentin, B Jover, M Maffre, et al.
Cardiovascular Toxicology|July 28, 2011
Carbon monoxide pollution impairs myocardial perfusion reserve: implication of coronary endothelial dysfunctionG Meyer, J Boissiere, S Tanguy, et al.
Clinical and Experimental Pharmacology & Physiology|September 1, 1987
Atrial natriuretic peptide release in the rabbit is independent of cardiac nerve activityB P McGrath, D Blake, B Jover, et al.
Pageof 7